Alcaftadine is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. This drug was approved in July 2010.
用于2岁以上人群过敏性结膜炎相关性眼部瘙痒的治疗。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.